Cost evolution of biological agents for the treatment of spondyloarthritis in a tertiary hospital: influential factors in price
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Clinical Pharmacy"
DOI: 10.1007/s11096-018-0703-z
Abstract: Background Spending on biological agents has risen dramatically due to the high cost of the drugs and the increased prevalence of spondyloarthritis. Objective To evaluate the annual cost per patient and cost for each biological… read more here.
Keywords: annual cost; biological agents; per patient; spondyloarthritis ... See more keywords
Annual cost savings of US$70 million with similar outcomes: vaccine procurement experience from Iraq
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Global Health"
DOI: 10.1136/bmjgh-2021-008005
Abstract: Program Division, UNICEF, New York, New York, USA General Directorate of Public Health, Ministry of Health, Baghdad, Iraq Health Section, UNICEF Iraq, Baghdad, Iraq EPI Department, MOH, Baghdad, Iraq Department of International Health, Johns Hopkins… read more here.
Keywords: health; iraq; baghdad iraq; savings million ... See more keywords